Bone Biologics Corporation (BBLG)

NASDAQ: BBLG · IEX Real-Time Price · USD
2.83
-0.15 (-5.03%)
At close: Jan 21, 2022 4:00 PM
3.00
0.17 (6.01%)
After-hours:Jan 21, 2022 7:51 PM EST

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year20202019201820172016201520142013201220112010 - 2007
Selling, General & Admin
0.481.352.693.9608.331.510.480.010
Upgrade
Research & Development
0.341.10.1-1.3320.413.670.620.1900
Upgrade
Other Operating Expenses
0000000.88000
Upgrade
Operating Expenses
0.832.452.792.6320.41123.010.670.010
Upgrade
Operating Income
-0.83-2.45-2.79-2.63-20.41-12-3.01-0.67-0.01-0
Upgrade
Interest Expense / Income
10.981.234.422.621.871.40.4100
Upgrade
Other Expense / Income
000.4102.8500.01000
Upgrade
Pretax Income
-1.82-3.42-4.43-7.05-25.88-13.87-4.42-1.08-0.01-0
Upgrade
Income Tax
000000.010000
Upgrade
Net Income
-1.82-3.42-4.43-7.05-25.88-13.88-4.42-1.08-0.01-0
Upgrade
Net Income Common
-1.82-3.42-4.43-7.05-25.88-13.88-4.42-1.08-0.01-0
Upgrade
Shares Outstanding (Basic)
3322211000
Upgrade
Shares Outstanding (Diluted)
3322211000
Upgrade
Shares Change
-0.17%45.07%29.09%3.46%32.21%90.36%36.82%118.56%0.00%-
Upgrade
EPS (Basic)
-0.63-1.18-2.20-4.53-17.25-12.25-7.50-2.50--
Upgrade
EPS (Diluted)
-0.63-1.18-2.20-4.53-17.25-12.25-7.50-2.50--
Upgrade
Free Cash Flow Per Share
-0.15-1.11-2.04-2.14-4.87-3.12-4.63-1.20-0.03-0.02
Upgrade
Effective Tax Rate
-0.09%-0.05%-0.04%-0.02%-0.01%-0.06%-0.04%-0.07%0.00%0.00%
Upgrade
EBITDA
-0.83-2.45-3.2-2.63-23.26-11.99-3.02-0.67-0.01-0
Upgrade
EBIT
-0.83-2.45-3.2-2.63-23.26-12-3.02-0.67-0.01-0
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).